retatrutide type 1 diabetes In the News... Tzield, Retatrutide, New Clues About and more! Substack Series 3 of 6:

Preclinical studies in rodents consistently show reduced alcohol intake with GLP-1 medications, but human clinical trials have produced mixed results

Potential serious reactions being monitored in research include pancreatitis, gallbladder problems, kidney-related complications and severe allergic reactions

However, robust clinical trial evidence is lacking, and current NICE guidance does not recommend GLP-1 agonists for treating alcohol use disorder

9 Secondary structure analysis of Exendin-4 and analogs simulated in water

People with preexisting GI symptoms may be more prone to discomfort or intolerance, though responses vary, and formal evidence is limited